Rang	Name	Position
1	Dr. Isao Teshirogi Ph.D.	CEO, President & Representative Director
2	Dr. John Apeler Keller Ph.D.	Senior Exec. Officer, SVP of R&D Supervisory Unit and Pharma. Tech. Research Div. & Director
3	Takuji Fujiwara	Accounting & Finance Manager
4	Mr. Takeshi Shiota Ph.D.	Corporate Officer and Senior VP of Corporate Quality Assurance, Ethics & Compliance Management Div.
5	Mr. Yoshimasa Kyokawa	Vice President of Corporate Communications & Secretary Office
6	Yoshihiro Furuya	Vice President of General Marketing and Compliance Officer of Corporate GXP Compliance Office
7	Mr. Kazuhiro Hatanaka	Senior Executive Officer & Senior VP of Corporate Supervisory Unit
8	Akira Kato Ph.D.	Senior Executive Officer & Senior VP of Supply Supervisory Unit
9	Mr. Toshinobu Iwasaki Ph.D.	Senior Executive Officer & Senior VP of Healthcare Business Supervisory Unit
10	Masashi Deguchi Ph.D.	Corporate Officer & Senior VP of Sustainability Management Division

Aufteilung der Investoren

Für dieses Unternehmen liegen derzeit keine Daten zu institutionellen Investoren vor.